ACDIS update: Regulatory Committee “hot topics” posted

The ACDIS Regulatory Committee is tasked with the reviewing regulatory policy, coding, and clinical updates, commenting to agencies on behalf of ACDIS, and providing summary, interpretation, and analysis to ACDIS members.

The Committee kicked off a new initiative for 2020, in which the committee selects common questions or topics submitted by ACDIS members, then investigates and researches the topic to offer the most up-to-date and appropriate advice.

ACDIS members can find these ongoing updates on the “Regulatory Committee Insight” page, located under the “Thought Leadership” tab.

In April, the committee tackled pancytopenia with febrile neutropenia and determining when each condition should be coded separately versus together. For May, the topic was arteriovenous malformation (AVM) and determining whether to code the condition as congenital or as acquired based on research. Both discussions can be found here.

Please note that any advice or findings included in the articles represent the conclusions and opinions from the Regulatory Committee. The advice and guidance do not replace or supersede any direction or guidelines set forth by your organization, facility, or the Cooperating Parties. Please consult your organization’s leadership and/or administration before implementing changes that may conflict with your organizational standards.

Please feel free to reach out to any members of the Regulatory Committee with questions, concerns, or comments. A complete list of all the 2020 Regulatory Committee members can be found here.